Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Annals of Neurology|February 1, 2011
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Clas Malmeström, Markus Axelsson, et al.Plos One|October 3, 2012
Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosisJohan Mellergård, Anders Tisell, Olof Dahlqvist Leinhard, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 28, 2022
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.European Journal of Neurology|May 18, 2022
Free vitamin D<sub>3</sub> index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.Journal of Neuroinflammation|April 27, 2023
Prominent epigenetic and transcriptomic changes in CD4<sup>+</sup> and CD8<sup>+</sup> T cells during and after pregnancy in women with multiple sclerosis and controlsAlberto Zenere, Sandra Hellberg, Georgia Papapavlou Lingehed, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 6, 2023
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damageDaniel Jons, Viktor Grut, Tomas Bergström, et al.JAMA Neurology|October 8, 2019
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable TherapiesGustavo Luna, Peter Alping, Joachim Burman, et al.Frontiers in Immunology|August 15, 2022
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancyGeorgia Papapavlou Lingehed, Sandra Hellberg, Jesse Huang, et al.Annals of Neurology|February 15, 2020
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis PatientsPeter Alping, Johan Askling, Joachim Burman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2014
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experienceJoachim Burman, Ellen Iacobaeus, Anders Svenningsson, et al.Pageof 6